North America leads with over 34% market share, while APAC shows a robust growth of 9.03%. Major players like Alcon, Carl ...

Corneal disease in patients with VKC and AKC ranges from Tranta's dots, superficial punctuate keratitis, shield ulcer, corneal plaque, corneal neovascularization, lipid infiltration, viral ...

Health Canada approves Aflivu, a biosimilar for retinal diseases, enhancing treatment options and affordability for Canadian patients.

Included in the agreement are ranibizumab-nuna 0.05 mL injection (BYOOVIZ), referencing LUCENTIS (ranibizumab), and ...

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that five abstracts were accepted for oral presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting to ...

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it has entered into a definitive agreement with Samsung Bioepis Co. Ltd. (hereafter “Samsung ...

Samsung Bioepis Co., Ltd. ("Samsung Bioepis") announced today that the company has entered into a license, development and ...

The Knights Templar Eye Foundation, Inc. presented a $90,000 research grant to Augusta University researcher.

Choroidal neovascularization in myopic macular degeneration can cause vision loss, but advances in treatment options may prevent that outcome for many. Learn more about these sight-saving therapies.

A new study suggests a potential link between the Pfizer COVID-19 vaccine and serious eye conditions like retinal vascular ...

Find the latest Cornea and External Disease and Ophthalmology news articles, videos, podcasts, and meeting coverage from medical experts and key opinion leaders you trust.